Understanding protein kinases’ involvement in melanoma, breast cancer, and pancreatic cancer could unveil new therapeutic possibilities, emphasizing the importance of continued research in identifying and developing innovative kinase inhibitors. The gene discussed is WEE1; the disease is breast carcinoma.